Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3231 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-351 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-346 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3341 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-341 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7115 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-712 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
filingDate |
2020-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2023-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b114bd05d2da7903213a3f088ffbd93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13ce7658d8f7767f4c1746c6fee62a11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab7dcdebf678bed9095b9a21630a0e04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_799a182bff3ed03e4b2abb89135d3e3f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_018a7469ab3b72d4f97807a85ab8b16a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_683a4c6a7dfe2e8675bb59898f9eafa8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08de7d670951960acc30d6228ef16c02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdabd97eba16b48293024e2d8bd4fe3d |
publicationDate |
2023-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-11542501-B2 |
titleOfInvention |
Antisense oligonucleotides targeting ATXN3 |
abstract |
The present invention relates to antisense LNA oligonucleotides (oligomers) complementary to ATXN3 pre-mRNA sequences, which are capable of inhibiting the expression of ATXN3 protein. Inhibition of ATXN3 expression is beneficial for the treatment of spinocerebellar ataxia. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022177883-A1 |
priorityDate |
2019-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |